疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

) K, i2 i% A/ T7 LApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

) f# g& F+ h6 a4 |5 C1 w! i* Bhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
* \5 p0 F( B, N( q7 v; g) t. k  P
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
$ s, M7 b" Q3 Y4 ?( j4 f4 Vaccine manufacturing 44
( j. p& k2 l! Q2 K7 a) g8 i5 Evolution of adjuvants across the centuries 58
; f" @3 d7 i7 p& X7 b. r6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
; w3 w' w7 |! u4 {5 f6 v: N7 Passive immunization 80
8 General immunization practices 88
3 K2 e" g$ _7 H' j3 a7 Q9 }SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
: r$ k' M5 l9 s' V3 v8 v; Z# U10 Anthrax vaccines 127
& o8 j1 }% q+ u. G3 r# Q11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
% E1 l* Z5 i0 W! X14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
/ V. O. X  L) f19 Japanese encephalitis vaccines 312
+ V4 K) V1 B8 ^- s  j. a, ]  d1 J20 Measles vaccines 352
: ]" ~. N  b( {& p0 l4 _21 Meningococcal vaccines 388
% e  p/ f4 O3 U22 Mumps vaccine 419
! i8 G' ^9 \$ v23 Pertussis vaccines . 447
24 Plague vaccines 493
9 Y6 h1 ~8 O: C' ?8 f+ `. @, n25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
  k' b: x' w" a: B29 Rabies vaccines .646
1 o& Y& n+ M3 H1 L) e+ A30 Rotavirus vaccines . 669
9 A- ^0 C- s% ]* G* G. y/ R31 Rubella vaccine 688
8 L+ d5 M$ v2 ]+ t* e0 ~! C32 Smallpox and vaccinia 718
0 A* w) y- M, z( p33 Tetanus toxoid 746
- a9 ^. f+ k9 m1 z9 v' r34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
% y/ H: J* h4 u1 Z$ s4 m$ C36 Typhoid fever vaccines 812
9 ^' L* N$ U9 H$ S/ k37 Varicella vaccine 837
1 o# R2 _" k) B* G( x! ^6 d0 |+ x38 Yellow fever vaccine 870
" }0 h; k" T3 \1 N; y! W# f39 Zoster vaccine 969
! y1 _8 J5 s6 b3 A/ ]( K& V6 Z40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
/ M. @+ m: L; {# a1 {  Q/ o42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
! n" W( E0 T1 F! G* F6 p46 Ebola vaccine 1060
  g, M3 g5 a. A3 l/ {3 T) z# I+ E47 Epstein-Barr virus vaccines 1068
- ]8 T7 F  P. \" @/ ]48 Hepatitis C vaccines 1074
* R% }( F3 }& `) o! q49 Hepatitis E vaccines 1085
7 A9 v/ L& \, y. U1 s50 Herpes simplex virus vaccines 1090
3 ~& C8 P9 ^" ]! G51 Human immunodeficiency virus vaccines 1097
+ w5 w. F6 A2 @/ t- t# ?* N7 x52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
7 V- V9 H& o& o54 Noninfectious disease vaccines 1138
  X" F; W# Z$ x$ F) _3 O. |55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
% }: ~6 S5 P3 h5 y7 @/ [58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
$ i5 t4 c' d; f" [7 @, f- j0 V61 Alternative vaccine delivery methods 1200
( D7 s/ q/ |% \62 The development of gene-based vectors for immunization 1232
! Q0 \( k# _) I5 v7 cSECTION 4: Vaccination of special groups
) R0 d! Q4 C3 ?5 d( i7 Y63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
  ^5 |$ b1 l" e. ?0 g/ K1 Z0 q66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
% V- z4 Y8 g% R67 Immunization in the United States 1310
4 z" m6 O1 u# e. a" ~0 M) r* l68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
' P( U9 R' x* U9 x4 y( @70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
5 n- C: i/ A( c/ O; C' ?73 Regulation and testing of vaccines 1427
# d1 n1 q1 O  [  m+ O74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
/ Q! ?) F& [& S% `6 a! A9 \: b5 \77 Legal issues . 1481
78 Ethics 1508


4 C% y8 y- v* ^0 c% F

" Y  w$ {" \1 e; t6 _5 v0 x

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

2 y- k( X% _5 ~. y) m4 ]/ Z" QVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

1 E% @' U" Z1 O. T9 k5 ~% b# x* Y' d8 Rhttp://yun.baidu.com/share/link? ... 1&uk=3810996606

/ y' J- R7 z7 |2 iSECTION 1: General aspects of vaccination
+ I+ {4 `# r) \* x$ \1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
: V2 Z& U3 k4 a0 I5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
: A. \: ?* T& u( e7 Passive immunization 80
# X6 {" _3 A8 o9 D% Y8 }$ m7 o8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
" ^* H1 a8 f( W7 l1 r10 Anthrax vaccines 127
11 Cholera vaccines 141
# T8 F" p# X7 k0 T12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
) ?4 x/ ^" m3 @& c2 ]18 Influenza vaccine-live 294
$ P7 o$ s& N5 b" R: t% |' G19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
5 v' E1 q+ V8 D! w3 |21 Meningococcal vaccines 388
- I6 G1 @# t2 ?# H22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
$ g+ C3 q" m; b" G5 R: G) N4 T  T25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
3 {4 @/ H: N. V0 j9 J27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
6 B  E8 J$ e  W/ l; S32 Smallpox and vaccinia 718
- R! w' _9 B1 u' D33 Tetanus toxoid 746
$ d0 H' z: b$ V, o3 w* C/ ~  S/ m34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
: C4 o, N; Q9 C# U. J  C37 Varicella vaccine 837
38 Yellow fever vaccine 870
7 k  q* s0 T) M# \/ c39 Zoster vaccine 969
4 Z5 ?6 I6 T0 t' y9 L40 Combination vaccines 981
/ c& G! t/ {3 x" t  v, ?5 d- L1 bSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
# x8 ~: g5 A: T4 E& w1 J8 @) p44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
3 d# t" I' `9 H  P7 X, R  j47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
/ O) t- |0 w$ X1 q; Z: K56 Parasitic disease vaccines 1154
7 r9 l5 h4 \: H: C! g57 Staphylococcus aureus vaccines 1161
' X4 I, A5 A( n: s* `58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
3 e! f# i. E! d; y# b9 }; j- Y- T60 Technologies for making new vaccines 1182
8 V4 n0 S; l+ V; ?61 Alternative vaccine delivery methods 1200
  M5 n- `" @3 T# @8 Q" @! N62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
9 `, U7 x9 t& }1 l0 @63 Vaccination of immunocompromised hosts 1243
! H* b* m2 ?3 C7 H3 f# X7 D64 Vaccination of human immunodeficiency virus-infected persons 1257
5 _3 S0 z0 x. X0 D- j8 w65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
9 S' a/ H+ f' y8 x& Z0 C68 Immunization in Europe . 1334
0 i) ?9 K+ u4 ^3 `) a/ s69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
  H/ G! F: ?7 P3 q7 \- ?1 f72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
5 }0 k" G. c0 ?6 ]75 Regulation of vaccines in developing countries 1454
% s2 \8 y5 m! C! k- y6 I76 Vaccine safety 1464
  m8 |8 y/ D, @, e) k. m5 V77 Legal issues . 1481
4 E7 o+ C5 [0 u# b$ K! v* ^78 Ethics 1508

/ i2 f) o: D! N- V

casarett

Vaccines, 6e, 2012

) h7 A4 E+ U5 ZHardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
8 ~/ M0 c# b! gLanguage: English
ISBN-10: 1455700908
7 o  f3 n' w* q6 YSize: 52.3mb (original pdf)

% [4 v9 |, A3 [2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
* g8 x6 }% d. q
4 t. u0 U6 [1 e. o* gGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
9 j; J' @% Q7 M! s: |Analyze the cost-benefit and cost-effectiveness of different vaccine options.
- C- p. I! t4 ^" T, v- y3 x7 _Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
8 u) i: s% `: z5 B+ S8 ]; h! a4 iMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
0 V5 h/ @2 J$ m. jStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96